Annual Working Capital
$1.90 B
+$225.79 M+13.50%
31 December 2023
Summary:
Jazz Pharmaceuticals annual working capital is currently $1.90 billion, with the most recent change of +$225.79 million (+13.50%) on 31 December 2023. During the last 3 years, it has risen by +$96.70 million (+5.37%). JAZZ annual working capital is now -13.13% below its all-time high of $2.19 billion, reached on 31 December 2020.JAZZ Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$3.36 B
+$1.23 B+58.09%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly working capital is currently $3.36 billion, with the most recent change of +$1.23 billion (+58.09%) on 30 September 2024. Over the past year, it has increased by +$1.46 billion (+76.98%). JAZZ quarterly working capital is now at all-time high.JAZZ Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +77.0% |
| 3 y3 years | +5.4% | +86.5% |
| 5 y5 years | +50.0% | +165.5% |
JAZZ Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.5% | at high | +100.9% |
| 5 y | 5 years | -13.1% | +50.0% | at high | +199.6% |
| alltime | all time | -13.1% | +1566.3% | at high | +2589.5% |
Jazz Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.36 B(+58.1%) |
| June 2024 | - | $2.13 B(+7.5%) |
| Mar 2024 | - | $1.98 B(+4.2%) |
| Dec 2023 | $1.90 B(+13.5%) | $1.90 B(+13.5%) |
| Sept 2023 | - | $1.67 B(-19.0%) |
| June 2023 | - | $2.06 B(+10.1%) |
| Mar 2023 | - | $1.88 B(+12.1%) |
| Dec 2022 | $1.67 B(-7.2%) | $1.67 B(-4.9%) |
| Sept 2022 | - | $1.76 B(-6.7%) |
| June 2022 | - | $1.89 B(+6.9%) |
| Mar 2022 | - | $1.76 B(-2.1%) |
| Dec 2021 | $1.80 B(-17.6%) | $1.80 B(-4.8%) |
| Sept 2021 | - | $1.89 B(-8.7%) |
| June 2021 | - | $2.07 B(-14.1%) |
| Mar 2021 | - | $2.41 B(+10.5%) |
| Dec 2020 | $2.19 B(+72.7%) | $2.19 B(+14.2%) |
| Sept 2020 | - | $1.91 B(+1.1%) |
| June 2020 | - | $1.89 B(+68.7%) |
| Mar 2020 | - | $1.12 B(-11.4%) |
| Dec 2019 | $1.27 B(+42.5%) | $1.27 B(+12.0%) |
| Sept 2019 | - | $1.13 B(+12.9%) |
| June 2019 | - | $1.00 B(+12.2%) |
| Mar 2019 | - | $891.62 M(+0.3%) |
| Dec 2018 | $888.52 M(+31.8%) | $888.52 M(-20.9%) |
| Sept 2018 | - | $1.12 B(+17.1%) |
| June 2018 | - | $958.98 M(+27.7%) |
| Mar 2018 | - | $750.70 M(+11.3%) |
| Dec 2017 | $674.33 M(+37.4%) | $674.33 M(+19.8%) |
| Sept 2017 | - | $562.77 M(+36.6%) |
| June 2017 | - | $412.11 M(+14.4%) |
| Mar 2017 | - | $360.08 M(-26.6%) |
| Dec 2016 | $490.66 M(-52.4%) | $490.66 M(-4.0%) |
| Sept 2016 | - | $511.37 M(-49.1%) |
| June 2016 | - | $1.00 B(+15.2%) |
| Mar 2016 | - | $871.79 M(-15.4%) |
| Dec 2015 | $1.03 B | $1.03 B(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $974.75 M(-4.4%) |
| June 2015 | - | $1.02 B(+15.6%) |
| Mar 2015 | - | $882.35 M(+10.4%) |
| Dec 2014 | $799.04 M(+21.0%) | $799.04 M(+22.0%) |
| Sept 2014 | - | $654.78 M(+88.6%) |
| June 2014 | - | $347.14 M(+24.3%) |
| Mar 2014 | - | $279.31 M(-57.7%) |
| Dec 2013 | $660.59 M(+83.5%) | $660.59 M(+8.9%) |
| Sept 2013 | - | $606.71 M(+10.3%) |
| June 2013 | - | $549.83 M(+36.2%) |
| Mar 2013 | - | $403.65 M(+12.1%) |
| Dec 2012 | $360.03 M(+146.2%) | $360.03 M(+74.4%) |
| Sept 2012 | - | $206.44 M(+90.9%) |
| June 2012 | - | $108.12 M(-51.4%) |
| Mar 2012 | - | $222.56 M(+52.2%) |
| Dec 2011 | $146.26 M(+907.2%) | $146.26 M(+54.6%) |
| Sept 2011 | - | $94.61 M(+72.7%) |
| June 2011 | - | $54.77 M(+64.0%) |
| Mar 2011 | - | $33.40 M(+130.0%) |
| Dec 2010 | $14.52 M(-165.2%) | $14.52 M(-160.0%) |
| June 2010 | - | -$24.20 M(-22.4%) |
| Mar 2010 | - | -$31.17 M(+39.9%) |
| Dec 2009 | -$22.29 M(-82.8%) | -$22.29 M(+148.6%) |
| Sept 2009 | - | -$8.97 M(-48.7%) |
| June 2009 | - | -$17.48 M(-87.0%) |
| Mar 2009 | - | -$134.99 M(+4.2%) |
| Dec 2008 | -$129.49 M(-263.4%) | -$129.49 M(-4067.3%) |
| Sept 2008 | - | $3.26 M(-3150.5%) |
| June 2008 | - | -$107.00 K(-100.2%) |
| Mar 2008 | - | $44.52 M(-43.8%) |
| Dec 2007 | $79.23 M(+29.8%) | $79.23 M(-30.3%) |
| Sept 2007 | - | $113.62 M(-12.3%) |
| June 2007 | - | $129.53 M(+122.3%) |
| Mar 2007 | - | $58.26 M(-4.6%) |
| Dec 2006 | $61.04 M(+658.5%) | $61.04 M(+658.5%) |
| Dec 2005 | $8.05 M | $8.05 M |
FAQ
- What is Jazz Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly working capital year-on-year change?
What is Jazz Pharmaceuticals annual working capital?
The current annual working capital of JAZZ is $1.90 B
What is the all time high annual working capital for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual working capital is $2.19 B
What is Jazz Pharmaceuticals quarterly working capital?
The current quarterly working capital of JAZZ is $3.36 B
What is the all time high quarterly working capital for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly working capital is $3.36 B
What is Jazz Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, JAZZ quarterly working capital has changed by +$1.46 B (+76.98%)